Targeting Mutant KRAS and Its Metabolic Dependencies in Pancreatic Cancer Using Lipid Nanoparticle Delivery Systems

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:864 / 864
页数:1
相关论文
共 50 条
  • [21] Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
    Carneiro, Tatiana J.
    Pinto, Joana
    Serrao, Eva M.
    Barros, Antonio S.
    Brindle, Kevin M.
    Gil, Ana M.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [22] KRAS mutant-specific interactions reveal mechanisms in pancreatic cancer tumorigenesis and metabolic function
    Sundararaj, Kamala
    Burge, Rachel
    Saberikashani, Samaneh
    Bialousow, Lucas
    Linke, Amanda
    Smith, Merissa
    Ostrowski, Michael C.
    O'Bryan, John P.
    Hobbs, G. Aaron
    CANCER RESEARCH, 2024, 84 (02)
  • [23] Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment
    Yamamoto, Keisuke
    Iwadate, Dosuke
    Kato, Hiroyuki
    Nakai, Yousuke
    Tateishi, Keisuke
    Fujishiro, Mitsuhiro
    CANCERS, 2022, 14 (18)
  • [24] Targeting the Oncogene KRAS Mutant Pancreatic Cancer by Synergistic Blocking of Lysosomal Acidification and Rapid Drug Release
    Kong, Chao
    Li, Yang
    Liu, Zhengsheng
    Ye, Junxiao
    Wang, Zhaohui
    Zhang, Ling
    Kong, Weijian
    Liu, Huiqin
    Liu, Chun
    Pang, Huanhuan
    Hu, Zeping
    Gao, Jinming
    Qian, Feng
    ACS NANO, 2019, 13 (04) : 4049 - 4063
  • [25] Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
    Han, Jieun
    Lim, Jaesung
    Wang, Chi-Pin James
    Han, Jun-Hyeok
    Shin, Ha Eun
    Kim, Se-Na
    Jeong, Dooyong
    Lee, Sang Hwi
    Chun, Bok-Hwan
    Park, Chun Gwon
    Park, Wooram
    NANO CONVERGENCE, 2023, 10 (01)
  • [26] Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
    Jieun Han
    Jaesung Lim
    Chi-Pin James Wang
    Jun-Hyeok Han
    Ha Eun Shin
    Se-Na Kim
    Dooyong Jeong
    Sang Hwi Lee
    Bok-Hwan Chun
    Chun Gwon Park
    Wooram Park
    Nano Convergence, 10
  • [27] Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
    Zhang Yang
    Shun-Qing Liang
    Liang Zhao
    Haitang Yang
    Thomas M. Marti
    Balazs Hegedüs
    Yanyun Gao
    Bin Zheng
    Chun Chen
    Wenxiang Wang
    Patrick Dorn
    Gregor J. Kocher
    Ralph A. Schmid
    Ren-Wang Peng
    Journal of Experimental & Clinical Cancer Research, 41
  • [28] Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer
    Juanjuan Feng
    Zhengke Lian
    Xinting Xia
    Yue Lu
    Kewen Hu
    Yunpeng Zhang
    Yanan Liu
    Longmiao Hu
    Kun Yuan
    Zhenliang Sun
    Xiufeng Pang
    Acta Pharmaceutica Sinica B, 2023, (03) : 1145 - 1163
  • [29] Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
    Yang, Zhang
    Liang, Shun-Qing
    Zhao, Liang
    Yang, Haitang
    Marti, Thomas M.
    Hegedus, Balazs
    Gao, Yanyun
    Zheng, Bin
    Chen, Chun
    Wang, Wenxiang
    Dorn, Patrick
    Kocher, Gregor J.
    Schmid, Ralph A.
    Peng, Ren-Wang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [30] Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer
    Feng, Juanjuan
    Lian, Zhengke
    Xia, Xinting
    Lu, Yue
    Hu, Kewen
    Zhang, Yunpeng
    Liu, Yanan
    Hu, Longmiao
    Yuan, Kun
    Sun, Zhenliang
    Pang, Xiufeng
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (03) : 1145 - 1163